PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Kidney Research and Clinical Practice10.23876/j.krcp.21.22220224114-13Prostaglandin E2 receptors as therapeutic targets in renal fibrosisHenricus A.M. Mutsaers, Rikke Nørregaardhttp://krcp-ksn.org/upload/pdf/j-krcp-21-222.pdf, http://krcp-ksn.org/journal/view.php?doi=10.23876/j.krcp.21.222, http://krcp-ksn.org/upload/pdf/j-krcp-21-222.pdf
British Journal of Pharmacology10.1111/bph.133312015172225239-5250Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?G O'Callaghan, A Houstonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbph.13331, http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13331/fullpdf
Cancer and Metastasis Reviews10.1007/s10555-011-9303-22011303-4449-463Prostaglandin E2 EP receptors as therapeutic targets in breast cancerJocelyn Reader, Dawn Holt, Amy Fultonhttp://link.springer.com/content/pdf/10.1007/s10555-011-9303-2.pdf, http://link.springer.com/article/10.1007/s10555-011-9303-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10555-011-9303-2
Prostaglandins & Other Lipid Mediators10.1016/j.prostaglandins.2020.1064992021152106499Prostaglandin E2 receptors and their role in gastrointestinal motility – Potential therapeutic targetsA. Heeney, AC. Rogers, H. Mohan, F. Mc Dermott, AW. Baird, DC. Winterhttps://api.elsevier.com/content/article/PII:S1098882320300927?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098882320300927?httpAccept=text/plain
Current Therapeutic Research10.1016/s0011-393x(02)80072-820026310669-681Cyclooxygenase isoforms and prostaglandin E2 receptors in the ductus arteriosusAsmàa Bouayad, Xin Hou, Daya R. Varma, Ronald I. Clyman, Jean-Claude Fouron, Sylvain Chemtobhttps://api.elsevier.com/content/article/PII:S0011393X02800728?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0011393X02800728?httpAccept=text/plain
Archives of Biochemistry and Biophysics10.1016/0003-9861(87)90473-51987259189-97Homologous regulation of prostaglandin E2 receptors in rat renal medullaCatherine Limas, Constantinos J. Limashttps://api.elsevier.com/content/article/PII:0003986187904735?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0003986187904735?httpAccept=text/plain
Journal of Cystic Fibrosis10.1016/s1569-1993(21)02034-8202120S290-S291611: Therapeutic potential of pharmacological activation of CFTR in the airway: In vitro experiments using forskolin, lubiprostone, prostaglandin E2, and Cact-A1C. Shaughnessy, S. Yadav, P. Bratcher, P. Zeitlinhttps://api.elsevier.com/content/article/PII:S1569199321020348?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1569199321020348?httpAccept=text/plain
Life Sciences10.1016/j.lfs.2010.11.0152011885-6201-205Prostaglandin E receptors as inflammatory therapeutic targets for atherosclerosisCui Yang, Xiuxia Liu, Qing Cao, Qian Liang, Xiaohua Qiuhttps://api.elsevier.com/content/article/PII:S0024320510005217?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0024320510005217?httpAccept=text/plain
Journal of Cystic Fibrosis10.1016/s1569-1993(09)60205-820098S52Prostaglandin E2 in exhaled breath condensate in cystic fibrosisL. Fila, J. Musil, M. Pruchahttps://api.elsevier.com/content/article/PII:S1569199309602058?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1569199309602058?httpAccept=text/plain
Kidney International10.1046/j.1523-1755.2002.00129.x2002611354-355Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal diseaseNilufer Broeders, Daniel Abramowiczhttps://api.elsevier.com/content/article/PII:S008525381548189X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S008525381548189X?httpAccept=text/plain